Oncoclínicas&Co is the leading oncology group in Latin America and a global leader in precision medicine, clinical trials, and integrated oncology solutions. In 2024, Oncoclínicas&Co and Al Faisaliah Group announced a joint venture to enter the Saudia Arabian market, establishing Oncoclinics. This partnership brings Oncoclínicas&Co’s expertise, state-of-the-art treatment modalities, and patient-centric tailored cancer care to the Kingdom, and will leverage Al Faisaliah Group’s extensive local know-how and experience in healthcare investment and operations.
Oncoclinics is redefining oncology care and setting a new standard for oncology excellence in Saudi Arabia by establishing the first hub-and-spoke network of specialized outpatient centers, starting in the heart of its capital, Riyadh. This model ensures that patients receive world-class care close to home, supported by advanced diagnostics, digital health solutions, and seamless coordination. Oncoclinics is set to revolutionize cancer care by reducing wait times, enhancing survival rates, and delivering holistic, multidisciplinary support.
Company Details
Oncoclinicas Saudi Arabia Questions
Oncoclinicas Saudi Arabia's website is https://www.oncoclinicsgroup.com/
Oncoclinicas Saudi Arabia's LinkedIn profile is https://sa.linkedin.com/company/oncoclinicasksa
Oncoclinicas Saudi Arabia has
47 employees.
View email and phone details for 47
employees at Oncoclinicas Saudi Arabia.
Oncoclinicas Saudi Arabia's industry is
Hospitals and Health Care
Oncoclinicas Saudi Arabia's top competitors are
King Faisal Specialist Hospital And Research Center,
Tawuniya,
Hapvida Notredame Intermédica,
Modern Electronics - Mec (Al-Faisaliah Group),
Alfa Company,
Instituto Oncoclínicas,
Onco Clinics Africa,
Oncoclinica - Oncologistas Associados,
Al-Faisaliah Group (Jsc),
Oncoclínicas&co.
Oncoclinicas Saudi Arabia's categories are Hospitals and Health Care
Oncoclinicas Saudi Arabia's founding year is 2024
